Anti Estrogen Powders
Anti-estrogens can be crucial to safe and effective anabolic steroid usage. There are a few key purposes to use them, and a few untraditional yet valuable alternative usages as well. We will go over both. Most of the uses vary due to the different mechanism of action for each drug; the way they work. Depending on the mechanism of action, a given anti-estrogen drug may be more or less suited to your unique need.
Testolactone is a synthetic antineoplastic agent that is structurally distinct from the androgen steroid nucleus in possessing a six-membered lactone ring in place of the usual five-membered carbocyclic D-ring. Despite some similarity to testosterone, testolactone has no in vivo androgenic effect.
Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body.
Raloxifene is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause (change of life; end of menstrual periods).
Aminoglutethimide is an adrenal steroid inhibitor. It works by blocking the production of a variety of hormones, including glucocorticoids, mineralocorticoids, estrogens, and androgens and is clinically used in the Treating Cushing syndrome and metastatic breast cancer. Aminoglutethimide is also used by body builders.
Formestane is a synthetic steroidal substance with antineoplastic activity. Formestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens.
Mesterolone is an orally applicable androgen, and DHT derivative,is sold under the brand proviron, In the late 70's and early 80'sMestero lone was used with some success in controlled studies ofmen suffering from various forms of depression.
emara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor.
Anastrozole is also called Arimidex. It is a type of hormone therapy called an aromatase inhibitor. Anastrozoles treats breast cancer in women who have had their menopause.
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy.